Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for

We identified a total of 14 studies with a low or medium risk of bias for use in our main network meta-analyses (NWMA) comparing the efficacy of drug therapies for early rheumatoid arthritis. Those findings are presented in our main report.

Frontiers Comparison of different types of therapy for overactive bladder: A systematic review and network meta-analysis

Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis

Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis

Chapter 10: Analysing data and undertaking meta-analyses

Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf

First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis - ScienceDirect

Effectiveness and Tolerability of Different Recommended Doses of PPIs and H2RAs in GERD: Network Meta-Analysis and GRADE system

Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf

Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis